Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Iovance Biotherapeutics Inc

IOVA
Current price
3.06 USD +0.01 USD (+0.33%)
Last closed 3.03 USD
ISIN US4622601007
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 003 303 552 USD
Yield for 12 month -73.89 %
1Y
3Y
5Y
10Y
15Y
IOVA
21.11.2021 - 28.11.2021

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer NSCLC and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20.91 USD

P/E ratio

Dividend Yield

Current Year

+164 070 000 USD

Last Year

+1 189 000 USD

Current Quarter

+73 694 000 USD

Last Quarter

+58 554 000 USD

Current Year

+40 075 000 USD

Last Year

-9 566 000 USD

Current Quarter

+28 151 000 USD

Last Quarter

+18 731 000 USD

Key Figures IOVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -362 108 992 USD
Operating Margin TTM -117.48 %
Price to Earnings
Return On Assets TTM -29.22 %
PEG Ratio
Return On Equity TTM -57.48 %
Wall Street Target Price 20.91 USD
Revenue TTM 164 070 000 USD
Book Value 2.33 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 15 189.20 %
Dividend Yield
Gross Profit TTM 40 075 000 USD
Earnings per share -1.28 USD
Diluted Eps TTM -1.28 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -226.84 %

Dividend Analytics IOVA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History IOVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:100
Payout Ratio
Last Split Date 26.09.2013

Stock Valuation IOVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.49
Price Sales TTM 6.12
Enterprise Value EBITDA -8.68
Price Book MRQ 1.41

Financials IOVA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IOVA

For 52 weeks

2.70 USD 14.23 USD
50 Day MA 4.37 USD
Shares Short Prior Month 67 304 707
200 Day MA 7.83 USD
Short Ratio 5.69
Shares Short 75 186 511
Short Percent 22.52 %